Risk and consequences of chemotherapyinduced thrombocytopenia in US clinical practice

Chemotherapy-induced thrombocytopenia (CIT) is a potentially serious complication that can lead to chemotherapy dose delays, dose reductions, or discontinuation, and increases the risk of serious bleeding events.